Up a level |
Tansley, Sarah L, Simou, Stefania, Shaddick, Gavin, Betteridge, Zoe E, Almeida, Beverley, Gunawardena, Harsha, Thomson, Wendy, Beresford, Michael W ORCID: 0000-0002-5400-9911, Midgle, Angela, Muntoni, Francesco et al (show 2 more authors)
(2017)
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.
JOURNAL OF AUTOIMMUNITY, 84.
pp. 55-64.
Decock, Diederik, Davies, Rebecca, Kearsley-Fleet, Lianne, Baildam, Eileen, Beresford, Michael ORCID: 0000-0002-5400-9911, Foster, Helen, Southwood, Taunton, Thomson, Wendy and Hyrich, Kimme
(2018)
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN A REAL-WORLD SETTING IN THE UNITED KINGDOM.
.
De Cock, Diederik, Kearsley-Fleet, Lianne, Baidam, Eileen, Beresford, Michael ORCID: 0000-0002-5400-9911, Foster, Helen, Southwood, Taunton, Thomson, Wendy and Hyrich, Kimme
(2018)
BIOSIMILAR USE IN CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS IN AREAL-WORLD SETTING IN THE UNITED KINGDOM.
.
Kearsley-Fleet, Lianne, Adam, Rebecca, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy and Hyrich, Kimme L
(2019)
Biosimilar use in children and young people with juvenile idiopathic arthritis in a real-world setting in the United Kingdom.
.
Sampath, Sunil, Sergeant, Jamie C, Viatte, Sebastien, Carrasco, Roberto, Cobb, Joanna, Smith, Samantha, Hinks, Anne, Wedderburn, Lucy R, Beresford, Michael W ORCID: 0000-0002-5400-9911, Hyrich, Kimme L et al (show 1 more authors)
(2016)
Clinical Factors Associated with Non-Response to Methotrexate in Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Response to Treatment Consortium.
.
Tansley, Sarah L, Tansley, Sarah L, Dunphy, Juliet, Jobling, Amelia AC, Carrasco, Roberto, Midgley, Angela, Beresford, Michael ORCID: 0000-0002-5400-9911, Dick, Andrew D, Wedderburn, Lucy R, Thomson, Wendy et al (show 2 more authors)
(2016)
A DENSE FINE SPECKLE PATTERN ON IMMUNOFLUORESCENCE IS STRONGLY ASSOCIATED WITH THE DEVELOPMENT OF UVEITIS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS.
.
Kearsley-Fleet, Lianne, Davies, Rebecca, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy and Hyrich, Kimme L
(2016)
Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers.
RHEUMATOLOGY, 55 (9).
pp. 1556-1565.
Kearsley-Fleet, Lianne, Heaf, Eleanor, Davies, Rebecca, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy, Hyrich, Kimme L and BCRD and BSPAR-ETN study groups,
(2020)
Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study.
The Lancet Rheumatology, 2 (4).
e217-e226.
Kearsley-Fleet, Lianne, Heaf, Eleanor D, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy and Hyrich, Kimme L
(2019)
HIGH SEQUENTIAL USE OF TUMOUR NECROSIS FACTOR INHIBITORS IN A COHORT OF CHILDREN AND YOUNG PEOPLE WITH JUVENILE IDIOPATHIC ARTHRITIS FROM THE UNITED KINGDOM.
.
Kearsley-Fleet, Lianne, Gonzalez, Laura Vicente, Steinke, Douglas, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy et al (show 1 more authors)
(2019)
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis.
RHEUMATOLOGY, 58 (8).
pp. 1453-1458.
Davies, Rebecca, Southwood, Taunton, Kearsley-Fleet, Lianne, Lunt, Mark, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Douglas, Sharon, Thomson, Wendy, De Cock, Diederik et al (show 1 more authors)
(2017)
Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.
ARCHIVES OF DISEASE IN CHILDHOOD, 102 (2).
pp. 206-207.
Shoop-Worrall, Stephanie JW ORCID: 0000-0002-9441-5535, Hyrich, Kimme L ORCID: 0000-0001-8242-9262, Wedderburn, Lucy R ORCID: 0000-0002-7495-1429, Thomson, Wendy, Geifman, Nophar ORCID: 0000-0003-2956-6676 and CAPS the CLUSTER Consortium,
(2021)
Patient-reported wellbeing and clinical disease measures over time captured by multivariate trajectories of disease activity in individuals with juvenile idiopathic arthritis in the UK: a multicentre prospective longitudinal study.
The Lancet. Rheumatology, 3 (2).
e111-e121.
Kearsley-Fleet, Lianne, Beresford, Michael W ORCID: 0000-0002-5400-9911, Davies, Rebecca, De Cock, Diederik, Baildam, Eileen, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy and Hyrich, Kimme L
(2019)
Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra.
RHEUMATOLOGY, 58 (1).
pp. 94-102.
Kearsley-Fleet, Lianne, Sampath, Sunil, McCann, Liza J, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Davies, Rebecca, De Cock, Diederik, Foster, Helen E, Southwood, Taunton R, Thomson, Wendy et al (show 1 more authors)
(2019)
Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
RHEUMATOLOGY, 58 (2).
pp. 331-335.
Kearsley-Fleet, Lianne, Davies, Rebecca, Page, Jennifer, Baildam, Eileen, Beresford, Michael ORCID: 0000-0002-5400-9911, Foster, Helen, Southwood, Taunton, Thomson, Wendy and Hyrich, Kimme
(2019)
WHAT TO CHOOSE: A SECOND TNFI OR AN ALTERNATIVE CLASS OF BIOLOGIC FOR PATIENTS WITH JIA WHO HAVE FAILED THEIR FIRST TNFI.
In: Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019.
Davies, Rebecca, De Cock, Diederik, Kearsley-Fleet, Lianne, Southwood, Taunton, Baildam, Eileen, Beresford, Michael W ORCID: 0000-0002-5400-9911, Foster, Helen E, Thomson, Wendy, Ramanan, Athimalaipet V and Hyrich, Kimme L
(2020)
The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data.
RHEUMATOLOGY, 59 (6).
pp. 1391-1397.